Table 1 Characteristics and treatment parameters of patients ≤ 45 years undergoing (C) RT for HNSCC (n = 99)
n (%) | |
|---|---|
Age, years old | |
Median | 43 |
Range | 18–45 |
Gender | |
Female | 16 (16,2) |
Male | 83 (83,8) |
ECOG | |
0 | 17 (17.2) |
1 | 45 (45.4) |
2 | 37 (37.4) |
T stage | |
T1 | 15 (15.2) |
T2 | 28 (28.3) |
T3 | 29 (29.3) |
T4 | 26 (26.3) |
Tx | 1 (1.0) |
N stage | |
N0 | 21 (21.2) |
N1 | 16 (16.2) |
N2 | 55 (55.6) |
N3 | 7 (7.1) |
UICC | |
I | 8 (8.1) |
II | 8 (8.1) |
III | 20 (20.2) |
IV | 63 (63.6) |
Grading | |
1 | 3 (3.0) |
2 | 67 (67.7) |
3 | 28 (28.3) |
Unknown | 1 (1.0) |
Tumor location | |
Oropharynx | 32 (32.3) |
Hypopharynx | 14 (14.1) |
Oral cavity | 37 (37.4) |
Larynx | 11 (11.1) |
Multilevel | 5 (5.1) |
Treatment | |
Surgery + adjuvant (C)RT | 70 (70.7) |
Definitive (C)RT | 29 (29.3) |
Smoking | |
Yes | 60 (60.6) |
No | 28 (28.3) |
Unknown | 11 (11.1) |
Alcohol | |
Yes | 42 (42.4) |
No | 44 (44.4) |
Unknown | 13 (13.2) |
Radiotherapy dose (Gy) | |
Median (IQR) | 64.0 (60.0–70.0) |
Concomitant chemotherapy | |
Yes | 58 (58.6) |
No | 41 (41.4) |